AI in Drug Discovery Market: 2022 Analysis of Key Trend, Industry Dynamics and Future Growth 2022-2029

AI in Drug Discovery Market size was valued at USD 1163.16 Mn. in 2022 and the total market revenue is expected to grow by 29.5% from 2023 to 2029, reaching nearly USD 7104.46 Mn.

AI in Drug Discovery Market Overview:

For the global industry's AI in Drug Discovery market analysis, a research team did thorough primary and secondary research. Secondary research was carried out in order to supplement existing data, segment the market, estimate overall market size, and anticipate market size and growth rate.

Market leaders are identified through primary and secondary research, and market revenue is calculated through primary and secondary research. The primary study included in-depth interviews with key thought leaders and industry professionals such as experienced front-line staff, CEOs, and marketing executives. In-depth interviews with key thought leaders and industry professionals, such as experienced front-line staff, CEOs, and marketing executives, were conducted as part of primary research, while secondary research included a review of the major manufacturers' annual and financial reports. Secondary sources are used to generate global market percentage splits, market shares, growth rates, and breakdowns, which are then validated against primary data.

AI in Drug Discovery Market Scope:

By identifying and evaluating market segments and projecting market size, the study aids understanding of the Global AI in Drug Discovery Market dynamic structure. In addition, the study includes a competitive analysis of major corporations based on price, financial status, application expansion goals, and geographical presence. The report also includes a PESTLE analysis to help shareholders prioritize their efforts and investments in the Global AI in Drug Discovery Market.

External and internal components that are expected to have a positive or negative impact on businesses have been investigated, providing decision-makers with a clear picture of the sector's future. The study also aids in understanding the dynamic structure of the Global AI in Drug Discovery Market by studying market segments and projecting AI in Drug Discovery Market size. The study serves as a resource for investors by providing a comprehensive depiction of the competitive analysis of major firms in the Global AI in Drug Discovery Market based on price, financial status, growth strategies, and geographical presence.

Segmentation:

The AI in Drug Discovery Market is divided into Software and Services based on Offering. The services sector is predicted to have the largest CAGR between 2022 and 2029 and to have the largest market share in the worldwide AI in drug discovery services market in 2022. The benefits associated with AI services and the significant demand for AI services among end users are the primary factors driving the growth of this market segment.

However, the software industry is also gaining ground in the field of artificial intelligence in drug discovery. For instance, many emerging businesses are concentrating on deep learning novel approaches and generative models, which have made it possible to use existing data to design molecules that are optimised in silico to satisfy all the requirements of the small molecules discovery project.

Details insights on this market, request for methodology here -https://www.maximizemarketresearch.com/request-sample/161733

Key Players: The key players are

• GNS Healthcare (US)
• BioSymetrics (US)
• BPGbio, Inc (US)
• Atomwise Inc (US)
• Insitro (US)
• NVIDIA Corporation (US)
• IBM Corporation (US)
• Microsoft Corporation (US)
• Aria Pharmaceuticals, Inc. (US)
• Insilico Medicine (US)
• NuMedii, Inc. (US)
• Owkin Inc. (US)
• Schrödinger, Inc. (US)
• DEEP GENOMICS (Canada)
• Cyclica (Canada)
• BenevolentAI (UK)
• Exscientia (UK)
• Iktos (France)
• Euretos (Netherlands)
• Evaxion Biotech A/S (Denmark)
• XtalPi Inc (China)
• Standigm (South Korea)

Please Contact Us On link:https://www.maximizemarketresearch.com/request-sample/161733

Regional Analysis:

An examination of the AI in Drug Discovery Market at the country level focuses on categories identified as potentially high-growth, countries with the largest market share, and countries with the highest development potential. North America (USA, Canada), South America, Asia Pacific (China, Japan, India, Korea), Europe (Germany, UK, France, Italy), and Other countries are the regional breakdowns in the AI in Drug Discovery Market report.

COVID-19 Impact Analysis on AI in Drug Discovery Market: The report covers COVID-19 impact on AI in Drug Discovery market.

Key Questions Answered in the AI in Drug Discovery Market Report are:

What will be the AI in Drug Discovery market's CAGR throughout the projected period?
Which market category emerged as the market leader in the AI in Drug Discovery market?
Who are the key players in the AI in Drug Discovery market?
How big will the AI in Drug Discovery market be in 2027?
Which firm had the biggest market share in the AI in Drug Discovery market?
About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India

[email protected]

+91 96071 95908, +91 9607365656